Technical Analysis for DSGN - Design Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 5.55 | 1.28% | 0.07 |
DSGN closed unchanged on Wednesday, November 20, 2024, on 40 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Flat | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 1.28% | |
| Narrow Range Bar | Range Contraction | 1.28% | |
| Stochastic Reached Oversold | Weakness | 1.28% | |
| Inside Day | Range Contraction | 1.28% | |
| Wide Bands | Range Expansion | 1.28% | |
| Oversold Stochastic | Weakness | 1.28% | |
| Fell Below 50 DMA | Bearish | 1.28% | |
| MACD Bearish Signal Line Cross | Bearish | 1.28% | |
| Wide Bands | Range Expansion | 1.28% | |
| Down 3 Days in a Row | Weakness | 1.28% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 3 hours ago |
| 50 DMA Support | about 4 hours ago |
| 50 DMA Resistance | about 4 hours ago |
| Up 3% | about 4 hours ago |
| Up 2% | about 4 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/11/2024
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. The company was incorporated in 2017 and is based in Carlsbad, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Rare Diseases Medical Genetics Neurological Disorders Stroke Degenerative Disease Myotonic Dystrophy Ataxia Fragile X Syndrome Friedreich's Ataxia Trinucleotide Repeat Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Rare Diseases Medical Genetics Neurological Disorders Stroke Degenerative Disease Myotonic Dystrophy Ataxia Fragile X Syndrome Friedreich's Ataxia Trinucleotide Repeat Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.77 |
| 52 Week Low | 2.13 |
| Average Volume | 180,851 |
| 200-Day Moving Average | 4.26 |
| 50-Day Moving Average | 5.53 |
| 20-Day Moving Average | 5.79 |
| 10-Day Moving Average | 6.12 |
| Average True Range | 0.51 |
| RSI (14) | 46.52 |
| ADX | 20.35 |
| +DI | 27.96 |
| -DI | 25.93 |
| Chandelier Exit (Long, 3 ATRs) | 6.23 |
| Chandelier Exit (Short, 3 ATRs) | 6.59 |
| Upper Bollinger Bands | 6.94 |
| Lower Bollinger Band | 4.64 |
| Percent B (%b) | 0.37 |
| BandWidth | 39.77 |
| MACD Line | 0.13 |
| MACD Signal Line | 0.21 |
| MACD Histogram | -0.0784 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.74 | ||||
| Resistance 3 (R3) | 5.72 | 5.61 | 5.69 | ||
| Resistance 2 (R2) | 5.61 | 5.55 | 5.62 | 5.68 | |
| Resistance 1 (R1) | 5.55 | 5.51 | 5.58 | 5.57 | 5.66 |
| Pivot Point | 5.44 | 5.44 | 5.46 | 5.45 | 5.44 |
| Support 1 (S1) | 5.38 | 5.38 | 5.41 | 5.40 | 5.30 |
| Support 2 (S2) | 5.27 | 5.34 | 5.28 | 5.28 | |
| Support 3 (S3) | 5.21 | 5.27 | 5.27 | ||
| Support 4 (S4) | 5.23 |
